Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height

Stopped Study design no longer relevant and no patients were recruited.

Conditions

• Infant, Small for Gestational Age

Interventions

• OTHER: post GH treatment observational study

Sponsor

Pfizer